echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Domestic vascular interventional surgical robot track ushered in "golden time"

    Domestic vascular interventional surgical robot track ushered in "golden time"

    • Last Update: 2022-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In recent years, vascular interventional surgical robots have gradually developed into a popular track
    based on significant clinical advantages and broad development prospects.
    Domestic and foreign enterprises in this field have their own advantages, and the direction of research and development technology is diversified
    .
    It is worth noting that the innovation strength of local enterprises is constantly increasing, and they are expected to gain competitive advantages
    in the international market.
    CIC Consulting predicts that from 2022 to 2030, the compound annual growth rate of China's vascular interventional surgical robot market will exceed 90%, far exceeding the global level
    .
     
     
    Effectively solve the pain points of traditional surgery
     
    Vascular intervention refers to the operation technology of using puncture needles, guidewires, catheters and other instruments to diagnose and treat through the vascular route under the guidance of medical imaging technology
    .
    The procedures of vascular interventional surgery mainly include: puncture, access establishment, imaging, balloon predilation, stent release, and withdrawal of the guidewire catheter
    .
    At present, in addition to puncture and replacement of guidewires, catheters and other operations, vascular interventional surgical robots can assist doctors to complete most of the above surgical steps
    .
     
    According to the functional classification, vascular interventional surgical robots can be divided into two categories, one can assist doctors in vascular interventional electrophysiological examination or treatment, and the other can assist doctors to complete angioplasty
    .
     
    According to the classification of application methods, vascular interventional surgical robots are mainly divided into three categories: coronary intervention, neurointervention, and peripheral intervention (including aortic intervention).

    Among them, the development of coronary interventional surgical robots is relatively mature, and most vascular interventional surgical robot companies have taken the lead in applying their products to percutaneous coronary intervention (PCI) surgery
    .
     
    Clinically, the pain points of traditional vascular interventional surgery need to be solved
    urgently.
    Traditional vascular interventional surgery has a high threshold and difficulty, and doctors have a long
    learning curve.
    Taking neurointerventional surgery as an example, because the neurovascular vessels are curved and fragile, doctors need to use many types and models of surgical instruments during the operation, and the operation process is complicated
    .
    Traditional vascular interventional surgery pays attention to practice makes perfect, doctors need to undergo long-term training, the cost of early cultivation is high, and the results are uncontrollable; The long course of surgery can also affect the state of the doctor, and some human errors may occur, resulting in a poor
    prognosis for patients.
    Moreover, the distribution of medical resources is uneven in various places, and the technical level of doctors is different, and it is difficult to standardize
    the surgical effect.
    In addition, during the procedure, the doctor needs to complete the operation under X-ray fluoroscopy of the cath lab, which is exposed to radiation for a long time and has great health risks
    .
     
    The emergence of vascular interventional surgical robots has greatly changed the doctor's operation mode
    on the basis of not changing the doctor's operation method.
    Doctors no longer need to directly operate human blood vessels, but with the help of the master-slave design of vascular interventional surgical robots, to achieve remote control, can reach the difficult to reach blood vessels by human hands, and complete more complex operations
    .
    In addition to promoting the standardization of interventional operations and improving surgical safety, vascular interventional surgical robots can also keep doctors away from the effects of radiation and effectively improve doctor acceptance
    .
     
    A number of technical barriers need to be broken through
     
    Based on significant clinical advantages, vascular interventional surgical robots have gradually become a hot track, and their development direction is diversified
    .
    Vascular interventional surgical robots have high technical barriers, integrating artificial intelligence, mechanics, electrical, biological simulation, image navigation and other professional knowledge
    .
    From the application level, the entry points of various companies are different, some focus on the standardization of coronary angiography, some focus on the precise positioning and release of stents and balloons, and some emphasize the coverage
    of the whole surgical process.
     
    Force feedback and precise motion control are the focus
    of the research and development of vascular interventional surgical robots.
    Surgical robots assist in vascular interventional surgery that loses some sensory information, and doctors have a strong
    need for force feedback.
    Based on force feedback technology, the surgical robot can accurately perceive the force of the instrument during interventional surgery, and transmit the resistance of the instrument to the doctor in real time, increasing the doctor's sense
    of tactile presence.
    However, at present, force feedback technology cannot meet the high-precision requirements of vascular interventional surgery, and most of them stay in the experimental stage
    .
     
    In the process of vascular interventional surgery, doctors need to use catheters, guidewires, balloons, stents and other instruments, and even in some links, doctors need to cooperate to operate catheters, guidewires, etc.

    in a relatively narrow space.
    Therefore, vascular interventional surgical robots need to meet the needs of multi-instrument collaborative operation to cover more links
    of vascular interventional surgery.
    In terms of mechanical structure, the vascular interventional surgical robot can integrate the catheter guidewire drive device, improve the design of the robotic arm, and improve the degree of
    operation freedom.
    In the control procedure, the flexibility of the instrument itself, the relative movement between different devices, and the diversity of interventional instruments should be fully considered, and the vascular interventional surgical robot should be adapted to various types of catheters and guidewires
    by using adaptive clamping technology and positioning sensing technology.
    At the same time, multi-device collaboration is not only a mechanical design and software control problem, vascular intervention robots also need to have better force feedback, multi-modal image fusion and other functions, and relevant enterprises should focus on developing new human-computer interaction methods and operation interfaces
    .
     
    In addition, surgical image navigation is also a key research and development direction
    that enterprises should pay attention to.
    Surgical image navigation is known as the eye and brain of vascular interventional surgical robots, which can integrate CT angiography (CTA), magnetic resonance imaging (MRI) and other medical imaging technologies to reconstruct the patient's three-dimensional vascular model, which helps doctors observe the overall shape of the lesion and its relationship
    with the surrounding structures from multiple angles.
    At the same time, image navigation can be used to locate the location of lesions and plan surgical paths, and realize real-time navigation functions
    by matching the original medical image information with the real-time motion information of medical devices.
     
    In general, vascular interventional surgical robots are the product of multidisciplinary intersection and combination, and relevant enterprises should fully consider the integration of technical modules and the overall coordination of
    the system.
    The above-mentioned technologies such as force feedback and multi-instrument collaboration are not a problem of a single technical module, and enterprises should integrate them into one to ensure the overall safety and stability
    of vascular interventional surgical robot products.
     
    China's market scale is growing rapidly
     
    At present, the global vascular interventional surgical robot market is developing rapidly, and the market scale is accelerating expansion
    .
    According to data released by CIC, the global vascular interventional surgical robot market is expected to reach US$180 million this year and reach US$4.
    48 billion in 2030, with a compound annual growth rate of 49.
    2%
    from 2022 to 2030.
     
    At this stage, only a few vascular interventional surgical robots have been approved for marketing in the world, and they are mainly concentrated in developed countries and regions
    such as the United States and Europe.
    For example, Siemens' vascular interventional surgical robot system CorPath GRX was approved by the US FDA in 2016 and obtained the EU CE certification in 2019 for auxiliary PCI surgery; The vascular interventional surgical robot R-OneTM of the French company Robocath also obtained CE certification in 2019 for auxiliary PCI surgery
    .
     
    China's vascular interventional surgical robot market is in an early stage of development, and no products have been approved for marketing
    .
    Many local companies such as MicroPort Medical Robot, Runmed Medical, Ruixin Medical, Weimei Medical, Huihe Medical and other local companies have laid out the field of vascular interventional surgical robots, and some products have entered the clinical trial stage
    .
     
    Although China's vascular interventional surgical robot industry started late, its market scale growth potential is huge
    .
    According to CIC Consulting, it is expected that China's vascular interventional surgical robot market will reach 34 million yuan this year and 5.
    824 billion yuan in 2030, with a compound annual growth rate of 90.
    3% from 2022 to 2030, exceeding the growth rate of the global vascular interventional surgical robot market (see figure for details).

     
    Local companies have unique advantages
     
    Looking at the world, the market in each country and region has its own characteristics
    .
    If you want to break through and enter the local market, relevant enterprises must first understand the characteristics of the local market, otherwise it is difficult to achieve market expansion
    in different countries and regions with the same model.
     
    At present, many foreign vascular interventional surgical robot companies are accelerating their entry into the Chinese market
    .
    For example, Siemens adopts a localization development strategy to accelerate the localization layout in the Chinese market; Robocat h of France and St er eotaxi of the United States have entered the Chinese market
    through cooperation with local enterprises.
    The above-mentioned foreign companies have developed vascular interventional surgical robots for an earlier time, and some products have been approved for marketing abroad, and the safety and efficacy of the products have been clinically verified
    .
     
    It is worth noting that local companies also have many unique advantages
    .
    In recent years, the state has vigorously encouraged medical device innovation and promoted the high-quality development of
    the medical device industry.
    With the support of relevant policies, the R&D strength of medical device enterprises such as vascular interventional surgical robots in China has been continuously enhanced
    .
    At the same time, with the development of social economy, China's medical environment is constantly improving, the total national health expenditure is increasing year by year, and the medical demand of residents is gradually developing
    from a single disease treatment demand to improving the quality of life and improving the quality of life.
    In addition, many domestic companies use cutting-edge technologies such as 5G, computational fluid dynamics, and image navigation for the research and development of vascular interventional surgical robots, promoting breakthroughs in China's vascular interventional surgical robot industry
    .
    Different from the "domestic replacement" development path of medical devices such as coronary stents, endoscopes, and staplers, the development path of domestic vascular interventional surgical robots will be a road
    of "domestic innovation".
    While domestic enterprises have local advantages, they are also expected to enter the international market and compete
    with foreign enterprises.
     
    Based on the broad development prospects, China's vascular interventional surgical robot enterprises are favored
    by capital.
    Since 2021, the financing in the field of vascular interventional surgical robots in China has been hot, and many billions of yuan-level financing have been born
    on this track.
     
    At this stage, most of the development focus of vascular interventional surgical robot companies is to develop the market
    .
    From the perspective of market structure, the vascular interventional surgical robot market will gradually move from decentralized to centralized
    .
    When the market gradually matures, some enterprises may be acquired and merged, and market resources will be effectively integrated; A small number of companies will take advantage of the rise, occupy the vast majority of the market share, and are expected to grow into representative companies
    in this field.
     
    Under this circumstance, enterprises with unique product advantages, strong innovation and research and development strength, market-oriented team experience and resources, complete patent layout, and strong supply chain management capabilities, production capacity and quality management capabilities are more likely to achieve long-term development
    .
    (Author: Arterial Network)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.